Genomatica, Inc.

Private Company Ticker Symbol™: (GENOMP)

What's included with your PrivCo Report Purchase:

Next Actions on Genomatica, Inc.:

Business Summary

Genomatica, Inc. is a privately-held, venture capital backed company that develops bio-manufacturing processes to produce various industrial chemicals. The company offers a bioprocess engineering platform, an integrated suite of computational and experimental technologies to design, create, and optimize microorganisms. Founded in 2000, Genomatica, Inc. is headquartered in San Diego, California.

Recent News, Updates, and Analysis

SOLARCITY To IPO On NASDAQ This Week, Aims To Raise $141 Million In Rocky Market For Clean-Tech IPOs, But ELON MUSK's Backing Raises Hopes For Sunshine; PrivCo Analyzes SOLARCITY's Financials And Its IPO's Strengths & Risks
Dec. 2012 December 10, 2010 7:45 pm EST - SolarCity is looking to price on NASDAQ this week. With a revised goal to raise $141 Million, down from $201 Million when it first filed - SolarCity is testing an IPO market that has generally given solar and clean-tech companies the cold shoulder. The only other clean-tech company to IPO this year is Enphase (March 2012). … Read More »

Overview & Corporate Organization

Basic Information

Company Tags:	VC Backed
Year Founded:	2000
Fiscal Year End:	12/31
City:	San Diego
State/Province:	California
Country:	United States
Phone:	View
Website:	www.genomatica.com

Industry Information

Industry Codes

PICS™:	15001™, 1000303™
NAICS:	View
SIC:	View

PrivCo Industries (Sector > Industry > Sub-Industry)

Technology > Biotechnology

Manufacturing & Industrial > Chemical Manufacturing > Biochemicals

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

Charts, Financials, and Statistics (Table Format)

Below are Genomatica, Inc. financials and other business metrics displayed in table format.
Copy & Paste Financials Into Spreadsheet or

Export All Genomatica, Inc. Financials To Excel

All data before 2006 is completely free to view! To access data from 2006 onward:

Worldwide
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Washington, D.C.
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Canada
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland and Labrador
Northwest Territories
Nova Scotia
Nunavut
Ontario
Prince Edward Island
Quebec
Saskatchewan
Yukon
Europe (all countries)
UK
Germany
France
Italy
Europe (excluding UK)
Asia-Pacific (all countries)
Australia
China
Hong Kong
India
South Korea
Taiwan
Japan
Asia-Pacific (excluding India)
Latin America (all countries)
Middle East & Africa (all countries)

Get Full Access To This Report	or	Upgrade to PrivCo Premium
$99 Single Company Access		Instant Full Site-Wide Access *Currently 50% Off Until May. 31!*

Income Statement	2010	2009	2008
Revenues	View	View	View
Selling, General and Administrative Expenses	View	View	View
Research and Development Expense (Excluding In - Process)	View	View	View
Total Operating Expenses excluding costs	View	View	View
Operating Income/(Loss)	View	View	View
Interest Expense	View	View	View
Other Interest Income	View	View	View
Net Income (Loss)	View	View	View
Comprehensive Unrealized Gain Loss on Derivatives	View	View	View
Total Comprehensive Net Income	View	View	View

Balance Sheet	2010	2009
Cash and Cash Equivalents	View	View
Current Marketable Securities	View	View
Cash, Cash Equivalents and Short-Term Investments	View	View
Net Accounts Receivable Trade	View	View
Current Other Assets	View	View
Current Assets	View	View
Net Property, Plant and Equipment	View	View
Restricted Cash	View	View
Noncurrent Other Assets	View	View
Assets	View	View
Accounts Payable and Accrued Expenses	View	View
Current Deferred/(Unearned) Revenue	View	View
Current Debt and Capital Lease Obligations	View	View
Current Other Liabilities	View	View
Current Liabilities	View	View
Capital Lease Obligations - Long-Term	View	View
Liabilities	View	View
Convertible Preferred Stock Obligations	View	View
Convertible Preferred Stock - Value (Excluding Additional Paid in Capital)	View	View
Common Stock - Value (Excluding Additional Paid in Capital)	View	View
Retained Earnings	View	View
Other Accumulated Comprehensive Income, Net of Tax Effect	View	View
Equity - Other	View	View
Stockholders' Equity	View	View
Liabilities and Stockholders' Equity	View	View

Cash Flow Statement	2010	2009	2008
Operating Activities Beginning Net Income	View	View	View
Depreciation (Non-Production)	View	View	View
Amortization	View	View	View
Adjustment Accretion	View	View	View
Adjustment Issuance Stock and or Warrants	View	View	View
Adjustment for Equity Based Compensation Expense	View	View	View
Adjustment Extraordinary Items	View	View	View
Other Adjustments to Common Stockholders' Net Income - Increase/(Decrease)	View	View	View
Change Accounts Receivable	View	View	View
Increase/(Decrease) in Other Current Assets	View	View	View
Increase/(Decrease) in Accounts Payable and Accrued Expenses	View	View	View
Net Cash Flows Provided By/(Used In) Operating Activities	View	View	View
Purchase of Property, Plant and Equipment	View	View	View
Purchase of Marketable Securities	View	View	View
Proceeds Sale Marketable Securities	View	View	View
Increase Decrease Restricted Funds	View	View	View
Net Cash Flows Provided By/(Used In) Investing Activities	View	View	View
Proceeds from Notes Payable	View	View	View
Repayments on Notes Payable	View	View	View
Reduction of Capital Lease Obligations	View	View	View
Proceeds from Issuance of Preferred Stock	View	View	View
Proceeds from Stock Options Exercised	View	View	View
Repurchase of Common Stock	View	View	View
Net Cash Flows Provided By/(Used In) Financing Activities	View	View	View
Increase/(Decrease) in Cash and Cash Equivalents	View	View	View
Cash and cash equivalents at the beginning of the year	View	View	View
Total Cash and cash equivalents at the end of the year	View	View	View
Cash Interest Expense	View	View	View
Fair Value of Assets Acquired	View	View	View

Financial Notes:
*	Genomatica, Inc. fiscal year end: 12/31

	Date	Investor	Round	Investor Type
	Jun. 2008	View	Other	Venture Capital
	Jun. 2008	View	Other	Venture Capital
	Jun. 2008	View	Other
Details		Total Round Other View
	Mar. 2010	View	C	Venture Capital
	Mar. 2010	View	C	Venture Capital
	Mar. 2010	View	C	Venture Capital
	Mar. 2010	View	C	Venture Capital
Details		Total Round C View
	Mar. 2011	View	Other	Venture Capital
	Mar. 2011	View	Other	Venture Capital
	Mar. 2011	View	Other	Venture Capital
	Mar. 2011	View	Other	Venture Capital
	Mar. 2011	View	Other	Venture Capital
Details		Total Round Other View
	Aug. 2012	View	D	Venture Capital
	Aug. 2012	View	D	Venture Capital
	Aug. 2012	View	D	Venture Capital
	Aug. 2012	View	D	Venture Capital
	Aug. 2012	View	D	Venture Capital
	Aug. 2012	View	D	Corporate
Details		Total Round D View
		Total of Funding Shown Above View

Choose Region(s):
Or Enter Location (US, CAN, UK): within miles
Annual Revenues search is available on PrivCo Premium. Upgrade to PrivCo Premium Subscription Annual Revenues:
Industry:
Go to Advanced Search

Genomatica, Inc.

Business Summary

Recent News, Updates, and Analysis

Overview & Corporate Organization

Basic Information

Industry Information

Industry Codes

PrivCo Industries (Sector > Industry > Sub-Industry)

Charts, Financials, and Statistics (Table Format)

Charts, Financials, and Statistics (Graphs)

Genomatica, Inc. Revenues ($ MM): (Displayed as graph)

Genomatica, Inc. Selling, General and Administrative Expenses ($ MM): (Displayed as graph)

Genomatica, Inc. Research and Development Expense (Excluding In - Process) ($ MM): (Displayed as graph)

Genomatica, Inc. Total Operating Expenses excluding costs ($ MM): (Displayed as graph)

Genomatica, Inc. Operating Income/(Loss) ($ MM): (Displayed as graph)

Genomatica, Inc. Interest Expense ($): (Displayed as graph)

Genomatica, Inc. Other Interest Income ($): (Displayed as graph)

Genomatica, Inc. Net Income (Loss) ($ MM): (Displayed as graph)

Genomatica, Inc. Comprehensive Unrealized Gain Loss on Derivatives ($): (Displayed as graph)

Genomatica, Inc. Total Comprehensive Net Income ($ MM): (Displayed as graph)

Genomatica, Inc. Cash and Cash Equivalents ($ MM): (Displayed as graph)

Genomatica, Inc. Current Marketable Securities ($ MM): (Displayed as graph)

Genomatica, Inc. Cash, Cash Equivalents and Short-Term Investments ($ MM): (Displayed as graph)

Genomatica, Inc. Net Accounts Receivable Trade ($ MM): (Displayed as graph)

Genomatica, Inc. Current Other Assets ($): (Displayed as graph)

Genomatica, Inc. Current Assets ($ MM): (Displayed as graph)

Genomatica, Inc. Net Property, Plant and Equipment ($ MM): (Displayed as graph)

Genomatica, Inc. Restricted Cash ($): (Displayed as graph)

Genomatica, Inc. Assets ($ MM): (Displayed as graph)

Genomatica, Inc. Accounts Payable and Accrued Expenses ($ MM): (Displayed as graph)

Genomatica, Inc. Current Deferred/(Unearned) Revenue ($ MM): (Displayed as graph)

Genomatica, Inc. Current Debt and Capital Lease Obligations ($): (Displayed as graph)

Genomatica, Inc. Current Liabilities ($ MM): (Displayed as graph)

Genomatica, Inc. Capital Lease Obligations - Long-Term ($): (Displayed as graph)

Genomatica, Inc. Liabilities ($ MM): (Displayed as graph)

Genomatica, Inc. Convertible Preferred Stock Obligations ($ MM): (Displayed as graph)

Genomatica, Inc. Convertible Preferred Stock - Value (Excluding Additional Paid in Capital) ($ MM): (Displayed as graph)

Genomatica, Inc. Common Stock - Value (Excluding Additional Paid in Capital) ($): (Displayed as graph)

Genomatica, Inc. Retained Earnings ($ MM): (Displayed as graph)

Genomatica, Inc. Other Accumulated Comprehensive Income, Net of Tax Effect ($): (Displayed as graph)

Genomatica, Inc. Equity - Other ($): (Displayed as graph)

Genomatica, Inc. Stockholders' Equity ($ MM): (Displayed as graph)

Genomatica, Inc. Liabilities and Stockholders' Equity ($ MM): (Displayed as graph)

Genomatica, Inc. Operating Activities Beginning Net Income ($ MM): (Displayed as graph)

Genomatica, Inc. Depreciation (Non-Production) ($): (Displayed as graph)

Genomatica, Inc. Adjustment Accretion ($): (Displayed as graph)

Genomatica, Inc. Adjustment Issuance Stock and or Warrants ($): (Displayed as graph)

Genomatica, Inc. Adjustment for Equity Based Compensation Expense ($): (Displayed as graph)

Genomatica, Inc. Adjustment Extraordinary Items ($): (Displayed as graph)

Genomatica, Inc. Change Accounts Receivable ($ MM): (Displayed as graph)

Genomatica, Inc. Increase/(Decrease) in Other Current Assets ($): (Displayed as graph)

Genomatica, Inc. Increase/(Decrease) in Accounts Payable and Accrued Expenses ($ MM): (Displayed as graph)

Genomatica, Inc. Net Cash Flows Provided By/(Used In) Operating Activities ($ MM): (Displayed as graph)

Genomatica, Inc. Purchase of Property, Plant and Equipment ($ MM): (Displayed as graph)

Genomatica, Inc. Purchase of Marketable Securities ($ MM): (Displayed as graph)

Genomatica, Inc. Proceeds Sale Marketable Securities ($ MM): (Displayed as graph)

Genomatica, Inc. Increase Decrease Restricted Funds ($): (Displayed as graph)

Genomatica, Inc. Net Cash Flows Provided By/(Used In) Investing Activities ($ MM): (Displayed as graph)

Genomatica, Inc. Repayments on Notes Payable ($): (Displayed as graph)

Genomatica, Inc. Reduction of Capital Lease Obligations ($): (Displayed as graph)

Genomatica, Inc. Proceeds from Issuance of Preferred Stock ($ MM): (Displayed as graph)

Genomatica, Inc. Proceeds from Stock Options Exercised ($): (Displayed as graph)

Genomatica, Inc. Repurchase of Common Stock ($): (Displayed as graph)

Genomatica, Inc. Net Cash Flows Provided By/(Used In) Financing Activities ($ MM): (Displayed as graph)

Genomatica, Inc. Increase/(Decrease) in Cash and Cash Equivalents ($ MM): (Displayed as graph)

Genomatica, Inc. Cash and cash equivalents at the beginning of the year ($ MM): (Displayed as graph)

Genomatica, Inc. Total Cash and cash equivalents at the end of the year ($ MM): (Displayed as graph)

Genomatica, Inc. Cash Interest Expense ($): (Displayed as graph)

Genomatica, Inc. Fair Value of Assets Acquired ($): (Displayed as graph)

VC/Funding Activity

Supplemental Resources

PrivCo Private Deals Newsletter.It's FREE!

Who We Serve

Problems We Solve

PrivCo

Genomatica, Inc. Revenues ($ MM):
(Displayed as graph)

Genomatica, Inc. Selling, General and Administrative Expenses ($ MM):
(Displayed as graph)

Genomatica, Inc. Research and Development Expense (Excluding In - Process) ($ MM):
(Displayed as graph)

Genomatica, Inc. Total Operating Expenses excluding costs ($ MM):
(Displayed as graph)

Genomatica, Inc. Operating Income/(Loss) ($ MM):
(Displayed as graph)

Genomatica, Inc. Interest Expense ($):
(Displayed as graph)

Genomatica, Inc. Other Interest Income ($):
(Displayed as graph)

Genomatica, Inc. Net Income (Loss) ($ MM):
(Displayed as graph)

Genomatica, Inc. Comprehensive Unrealized Gain Loss on Derivatives ($):
(Displayed as graph)

Genomatica, Inc. Total Comprehensive Net Income ($ MM):
(Displayed as graph)

Genomatica, Inc. Cash and Cash Equivalents ($ MM):
(Displayed as graph)

Genomatica, Inc. Current Marketable Securities ($ MM):
(Displayed as graph)

Genomatica, Inc. Cash, Cash Equivalents and Short-Term Investments ($ MM):
(Displayed as graph)

Genomatica, Inc. Net Accounts Receivable Trade ($ MM):
(Displayed as graph)

Genomatica, Inc. Current Other Assets ($):
(Displayed as graph)

Genomatica, Inc. Current Assets ($ MM):
(Displayed as graph)

Genomatica, Inc. Net Property, Plant and Equipment ($ MM):
(Displayed as graph)

Genomatica, Inc. Restricted Cash ($):
(Displayed as graph)

Genomatica, Inc. Assets ($ MM):
(Displayed as graph)

Genomatica, Inc. Accounts Payable and Accrued Expenses ($ MM):
(Displayed as graph)

Genomatica, Inc. Current Deferred/(Unearned) Revenue ($ MM):
(Displayed as graph)

Genomatica, Inc. Current Debt and Capital Lease Obligations ($):
(Displayed as graph)

Genomatica, Inc. Current Liabilities ($ MM):
(Displayed as graph)

Genomatica, Inc. Capital Lease Obligations - Long-Term ($):
(Displayed as graph)

Genomatica, Inc. Liabilities ($ MM):
(Displayed as graph)

Genomatica, Inc. Convertible Preferred Stock Obligations ($ MM):
(Displayed as graph)

Genomatica, Inc. Convertible Preferred Stock - Value (Excluding Additional Paid in Capital) ($ MM):
(Displayed as graph)

Genomatica, Inc. Common Stock - Value (Excluding Additional Paid in Capital) ($):
(Displayed as graph)

Genomatica, Inc. Retained Earnings ($ MM):
(Displayed as graph)

Genomatica, Inc. Other Accumulated Comprehensive Income, Net of Tax Effect ($):
(Displayed as graph)

Genomatica, Inc. Equity - Other ($):
(Displayed as graph)

Genomatica, Inc. Stockholders' Equity ($ MM):
(Displayed as graph)

Genomatica, Inc. Liabilities and Stockholders' Equity ($ MM):
(Displayed as graph)

Genomatica, Inc. Operating Activities Beginning Net Income ($ MM):
(Displayed as graph)

Genomatica, Inc. Depreciation (Non-Production) ($):
(Displayed as graph)

Genomatica, Inc. Adjustment Accretion ($):
(Displayed as graph)

Genomatica, Inc. Adjustment Issuance Stock and or Warrants ($):
(Displayed as graph)

Genomatica, Inc. Adjustment for Equity Based Compensation Expense ($):
(Displayed as graph)

Genomatica, Inc. Adjustment Extraordinary Items ($):
(Displayed as graph)

Genomatica, Inc. Change Accounts Receivable ($ MM):
(Displayed as graph)

Genomatica, Inc. Increase/(Decrease) in Other Current Assets ($):
(Displayed as graph)

Genomatica, Inc. Increase/(Decrease) in Accounts Payable and Accrued Expenses ($ MM):
(Displayed as graph)

Genomatica, Inc. Net Cash Flows Provided By/(Used In) Operating Activities ($ MM):
(Displayed as graph)

Genomatica, Inc. Purchase of Property, Plant and Equipment ($ MM):
(Displayed as graph)

Genomatica, Inc. Purchase of Marketable Securities ($ MM):
(Displayed as graph)

Genomatica, Inc. Proceeds Sale Marketable Securities ($ MM):
(Displayed as graph)

Genomatica, Inc. Increase Decrease Restricted Funds ($):
(Displayed as graph)

Genomatica, Inc. Net Cash Flows Provided By/(Used In) Investing Activities ($ MM):
(Displayed as graph)

Genomatica, Inc. Repayments on Notes Payable ($):
(Displayed as graph)

Genomatica, Inc. Reduction of Capital Lease Obligations ($):
(Displayed as graph)

Genomatica, Inc. Proceeds from Issuance of Preferred Stock ($ MM):
(Displayed as graph)

Genomatica, Inc. Proceeds from Stock Options Exercised ($):
(Displayed as graph)

Genomatica, Inc. Repurchase of Common Stock ($):
(Displayed as graph)

Genomatica, Inc. Net Cash Flows Provided By/(Used In) Financing Activities ($ MM):
(Displayed as graph)

Genomatica, Inc. Increase/(Decrease) in Cash and Cash Equivalents ($ MM):
(Displayed as graph)

Genomatica, Inc. Cash and cash equivalents at the beginning of the year ($ MM):
(Displayed as graph)

Genomatica, Inc. Total Cash and cash equivalents at the end of the year ($ MM):
(Displayed as graph)

Genomatica, Inc. Cash Interest Expense ($):
(Displayed as graph)

Genomatica, Inc. Fair Value of Assets Acquired ($):
(Displayed as graph)

PrivCo Private Deals Newsletter.
It's FREE!